Hsieh et al. [103] reported the inhibition of HIF-1 activation and tumor growth by tempol, while Chou et al. [94] investigated the ability of YC-1 to enhance the efficacy of chemotherapy BCNU. This evidence concerns the gene HIF1A and neoplasm.